<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00235196</url>
  </required_header>
  <id_info>
    <org_study_id>400-04-001</org_study_id>
    <nct_id>NCT00235196</nct_id>
  </id_info>
  <brief_title>Evaluation of the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers</brief_title>
  <official_title>A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Full-Thickness, Neuropathic Diabetic Foot Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ethicon, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ethicon, Inc.</source>
  <brief_summary>
    <textblock>
      This is a randomized (1:1), prospective, open label, multicenter, comparative study to be&#xD;
      examine the effectiveness of Collagen-ORC Antimicrobial matrix, a new wound dressing, on&#xD;
      diabetic foot ulcers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2004</start_date>
  <completion_date>December 2005</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical effectiveness of CAM in DFU by comparing the reduction in wound area between 2 treatment groups.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of wound closure</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of use and adverse events</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound odor</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound characteristics</measure>
  </secondary_outcome>
  <enrollment>48</enrollment>
  <condition>Foot Ulcer</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Collagen ORC Antimicrobial Matrix (CAM)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older.&#xD;
&#xD;
          -  Ambulatory (i.e. walking is the primary method of mobilization. Crutches, walker,&#xD;
             walking frame or other ambulation aids are permitted).&#xD;
&#xD;
          -  Diagnosed Type 2 diabetic (i.e. not juvenile onset).&#xD;
&#xD;
          -  Have a DFU on the plantar surface of either foot.&#xD;
&#xD;
          -  Have a DFU of &gt;4 wks but &lt;6 months duration.&#xD;
&#xD;
          -  Willing and capable of cooperating to the extent and degree required by the study&#xD;
             protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Be &lt; 1cm2 or &gt;10cm2 in area, by planimetry.&#xD;
&#xD;
          -  Demonstrate overt signs of infection.&#xD;
&#xD;
          -  Be located on the dorsal, lateral, or posterior heel area of the foot (Change 2,&#xD;
             Amendment 1).&#xD;
&#xD;
          -  Have visible exposed bone or tendon.&#xD;
&#xD;
          -  Have an adjacent thermal injury or wound of an etiology other than diabetes.&#xD;
&#xD;
          -  Be within 5 cm of any other wound, regardless of etiology.&#xD;
&#xD;
          -  Have received enzymatic debriding agents in the past 7 days.&#xD;
&#xD;
          -  Have received topical antibiotic therapy in the past 7 days.&#xD;
&#xD;
          -  Be less than 1 cm2 or exceed 10cm2 in area by planimetry, after debridement.&#xD;
&#xD;
          -  Have exposed bone or tendon, after debridement&#xD;
&#xD;
        The study subject MUST NOT:&#xD;
&#xD;
          -  Have received previous treatment for the study ulcer by this Investigator.&#xD;
&#xD;
          -  Have more than 3 full thickness ulcers, in total.&#xD;
&#xD;
          -  Be pregnant or nursing an infant&#xD;
&#xD;
          -  Have a concurrent illness or condition which may interfere with wound healing, such as&#xD;
             carcinoma, vasculitis, immune system disorders or connective tissue disorder.&#xD;
&#xD;
          -  Be a known alcohol or drug abuser.&#xD;
&#xD;
          -  Have received systemic corticosteroids, immunosuppressive or chemotherapeutic agents&#xD;
             in the past 30 days.&#xD;
&#xD;
          -  Have received radiotherapy, which includes the lower extremity, at any time.&#xD;
&#xD;
          -  Have a marked Charcot foot or claw foot deformity which would limit the ability of the&#xD;
             subject to wear or be compliant with the wearing of the standardized off-loading&#xD;
             device used in this study.&#xD;
&#xD;
          -  Have received an investigational drug or device in the past 30 days.&#xD;
&#xD;
          -  Have a known hypersensitivity to bovine collagen, oxidized regenerated cellulose (ORC)&#xD;
             or silver.&#xD;
&#xD;
          -  Be unwilling or unable to be fitted or compliant with the wearing of an ulcer&#xD;
             off-loading device.&#xD;
&#xD;
          -  Known to be non-compliant or unlikely to complete the study.&#xD;
&#xD;
          -  Have ABPI &lt; 0.7, OR, if ABPI &gt;1.0 and toe pressure &gt;0.6.&#xD;
&#xD;
          -  Have serum Creatinine &gt; 3 mg/dL25. have Hgb A1C&gt;9%&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>James Hart, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ethicon, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wound Care Center</name>
      <address>
        <city>Ft. Lauderdale</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foot and Ankle Institute of South Florida</name>
      <address>
        <city>South Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penn North Centers for Advanced Wound Care</name>
      <address>
        <city>Warren</city>
        <state>Pennsylvania</state>
        <zip>16365</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2006</verification_date>
  <study_first_submitted>October 6, 2005</study_first_submitted>
  <study_first_submitted_qc>October 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2005</study_first_posted>
  <last_update_submitted>October 12, 2006</last_update_submitted>
  <last_update_submitted_qc>October 12, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 13, 2006</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

